NCT06319378View on ClinicalTrials.gov

Cancer Related Major Depression Treated With a Single Dose of Psilocybin

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 17, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
MDD
Interventions
DRUG

psilocybin 25 mg sod

psilocybin 25 mg sod

DRUG

psilocybin 1 mg sod

active placebo

Trial Locations (4)

Unknown

RECRUITING

region Västra Götaland, Gothenburg

RECRUITING

Örebro sjukhus, Örebro

RECRUITING

Norra Stockholms Psykiatri, Stockholm

RECRUITING

Psykiatriska Kliniken, Akademiska Sjukhuset, Uppsala

All Listed Sponsors
collaborator

Uppsala University Hospital

OTHER

collaborator

Region Örebro County

OTHER

collaborator

Vastra Gotaland Region

OTHER_GOV

collaborator

Karolinska Institutet

OTHER

lead

Section for Affective Disorders; Northern Stockholm Psychiatry

OTHER